Risk and Severity of COVID-19 in Patients With Rheumatic Disorders Receiving DMARDs vs Methotrexate
Study authors examined the risk for admission and respiratory failure in patients with rheumatic disorders with COVID-19 receiving DMARDs or methotrexate.